Abstract:Introduction: Despite continued improvement in post-sepsis survival, long term morbidity and mortality remain high. Chronic critical illness (CCI), defined as persistent inflammation and organ injury requiring prolonged intensive care, is a harbinger of poor long-term outcomes in sepsis survivors. Current dogma states that sepsis survivors are immunosuppressed, particularly in CCI. Investigation of this immune suppression in heterogeneous immune populations across distinct clinical trajectories and outcomes, along with limited sampling access, is accessible via single-cell RNA sequencing (scRNA-seq). Methods: scRNA-seq analysis was performed on healthy subjects (n=12), acutely septic patients at day 4 ± 1 (n=4), and those defined as rapid recovery (n=4) or CCI (n=5) at day 14-21. Differential gene expression and pathway analyses were performed on peripheral blood lymphocytes at both a population and annotated cell subset level. Cellular function was assessed via enzyme-linked immunosorbent spot (ELISpot), cytokine production analysis, and T-cell proliferation assays on an additional cohort of septic patients (19 healthy, 68 acutely septic, 27 rapid recovery and 20 classified as CCI 14-21 days after sepsis onset). Results: Sepsis survivors that developed CCI exhibited proportional shifts within lymphoid cell populations, with expanded frequency of CD8 + and NK cells. Differential expression and pathway analyses revealed continued activation in T cells and NK cells, with generalized suppression of B-cell function. Both T and NK cell subsets displayed transcriptomic profiles of exhaustion and immunosuppression in CCI, particularly in CD8 + T effector memory (TEM) cells and NK cells. Functional validation of T-cell behavior in an independent cohort demonstrated T cells maintained proliferative responses in vitro yet exhibited a marked loss of cytokine production. IFN-γ production at the acute phase (day 4 ± 1) was significantly reduced in subjects later classified as CCI. Discussion: Sepsis patients exhibit unique T-, B-, and NK-cell transcriptional patterns that are both time- and clinical trajectory-dependent. These transcriptomic and pathway differences in sepsis patients that develop CCI are associated with exhaustion in CD8 + TEM cells and NK cells. Understanding the specific immune system patterns of different cell subsets after sepsis at a molecular level will be key to the development of personalized immunotherapy and drug-targeting intervention. Clinical trial registration: https://clinicaltrials.gov/, identifier NCT02276417.

Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia

Comprehensive Transcriptome Profiling of Peripheral Blood Mononuclear Cells from Patients with Sepsis

Bulk and Single-Cell Transcriptome Analysis Reveal Shared Key Genes and Patterns of Immune Dysregulation in Sepsis and Systemic Lupus Erythematosus

The landscape of isoform switches in sepsis: a multicenter cohort study

Sepsis endotypes identified by host gene expression across global cohorts

Footprints of Sepsis Framed Within Community Acquired Pneumonia in the Blood Transcriptome

An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression

Host and Microbe Blood Metagenomics Reveals Key Pathways Characterizing Critical Illness Phenotypes

The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination

Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes

Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illness

Inflammatory sub-phenotypes in sepsis: relationship to outcomes, treatment effect and transcriptomic sub-phenotypes

High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response

Dynamic changes in human single-cell transcriptional signatures during fatal sepsis

Commonly Expressed Key Transcriptomic Profiles of Sepsis in the Human Circulation and Brain Via Integrated Analysis.

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis

Prognostic and predictive enrichment in sepsis

Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections

Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures

Distinct functional neutrophil phenotypes in sepsis patients correlate with disease severity

Temporal Changes In Innate And Adaptive Immunity During Sepsis As Determined By Elispot